ABSTRACT
The objectives of this study were to assess Candida spp. distribution and antifungal resistance of candidaemia across Europe. Isolates were collected as part of the third ECMM Candida European multicentre observational study, conducted from 01 to 07-07-2018 to 31-03-2022. Each centre (maximum number/country determined by population size) included â¼10 consecutive cases. Isolates were referred to central laboratories and identified by morphology and MALDI-TOF, supplemented by ITS-sequencing when needed. EUCAST MICs were determined for five antifungals. fks sequencing was performed for echinocandin resistant isolates. The 399 isolates from 41 centres in 17 countries included C. albicans (47.1%), C. glabrata (22.3%), C. parapsilosis (15.0%), C. tropicalis (6.3%), C. dubliniensis and C. krusei (2.3% each) and other species (4.8%). Austria had the highest C. albicans proportion (77%), Czech Republic, France and UK the highest C. glabrata proportions (25-33%) while Italy and Turkey had the highest C. parapsilosis proportions (24-26%). All isolates were amphotericin B susceptible. Fluconazole resistance was found in 4% C. tropicalis, 12% C. glabrata (from six countries across Europe), 17% C. parapsilosis (from Greece, Italy, and Turkey) and 20% other Candida spp. Four isolates were anidulafungin and micafungin resistant/non-wild-type and five resistant to micafungin only. Three/3 and 2/5 of these were sequenced and harboured fks-alterations including a novel L657W in C. parapsilosis. The epidemiology varied among centres and countries. Acquired echinocandin resistance was rare but included differential susceptibility to anidulafungin and micafungin, and resistant C. parapsilosis. Fluconazole and voriconazole cross-resistance was common in C. glabrata and C. parapsilosis but with different geographical prevalence.
ABSTRACT
OBJECTIVES: The aim of the present study was to evaluate the Streptococcus mutans and Streptococcus mitis adhesion and related surface properties of bulk-fill resin composite. METHODS: Four novel bulk-fill composite with different composition were used; Sonic Fill-2 (KSF), Filtek BulkFill (FBF), Admira Fusion X-tra (AFX), Beautifil Bulk Restorative (SBB) and a control group (glass) were included in the study. After standardized surface polishing procedure, surface properties of composite specimens were evaluated using surface roughness (SR) measurements by a profilometer, hydrophobicity and surface free energy (SFE) analyses, elemental and topographic analyses by SEM-EDS. To evaluate the bacterial adhesion, composite specimens were immersed in artificial saliva and mucin for pellicle development. After 1-h immersion, bacterial suspension was added to the pellicle-coated specimens, which were incubated at 37 °C in 5% CO2 atmosphere for 24 h. Adhered bacteria counts were determined as x108 Cfu/ml. Bacterial adhesion was also investigated using confocal laser scanning microscopy. RESULTS: No statistically significant differences were found among bulk fill composites in terms of surface roughness while glass showed the lowest Ra values. The lowest contact angle values were found in the control group and Sonic Fill-2 while the highest SFE values were observed in these materials. No statistically significant differences were found between the S. mutans counts. For S. Mitis adhesion, the highest value was found in Sonic Fill-2 and no significant differences were observed between the other groups. CONCLUSIONS: SR of bulk-fill composite resins had no effect on bacterial adhesion. However, bacterial adhesion increased with higher SFE values. CLINICAL SIGNIFICANCE: Although the surface roughness of composites used in the study is similar, in clinically, S. mitis adhesion may be more in the KSF group because of high surface free energy.
